ASX-Dividend-Report-Banner

Proto Axiom Launches The Challenger Summit: Australia's Premier Biotech Pitch-Event with over $250,000 in Grant Financing

May 21, 2024 01:28 PM AEST | By Cision
 Proto Axiom Launches The Challenger Summit: Australia's Premier Biotech Pitch-Event with over $250,000 in Grant Financing
Image source: Kalkine Media

SYDNEY, May 21, 2024 /PRNewswire/ -- Proto Axiom, Australia's first true biotech incubator, is thrilled to announce the launch of The Challenger Summit.

The Challenger Summit will provide a unique platform for researchers to showcase their innovative biotech solutions, competing for over $250,000 in unencumbered grant financing.

This inaugural pitch-event is designed to bring together the brightest minds from Australian universities, research institutes, and public health systems.

The significant funding aims to accelerate research and drive the development of cutting-edge biotechnologies in Australia.

Entries for The Challenger Summit are due by 12 July 2024.

All eligible researchers can present their projects and gain invaluable exposure and support from industry leaders.

The Summit will take place in October 2024 at the St. Vincent's Health Innovation Precinct in Sydney, a renowned organisation that brings together world-leading researchers and clinicians dedicated to excellence in medical research.

"We are excited to host The Challenger Summit and look forward to seeing the innovative ideas that will shape the future of biotechnology," Anthony Liveris, CEO of Proto Axiom said.

"This event underscores our commitment to fostering a vibrant biotech ecosystem in Australia and supporting the next generation of researchers."

For more information about The Challenger Summit, including entry requirements and event details, please visit protoaxiom.com

About Proto Axiom

Proto Axiom is Australia's first true biotech incubator, dedicated to nurturing and accelerating the growth of early-stage biotech ventures. By providing essential resources, mentorship, and funding, Proto Axiom aims to transform innovative ideas into successful biotech solutions that address global health challenges. Our hands-on approach to support Australian research is a first-in-country model.



Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.